(Z)-2-(2-Aminothiazole-4-yl)-2-[(trityloxy)imino]acetic acid

Product Overview

(Z)-2-(2-Aminothiazole-4-yl)-2-[(trityloxy)imino]acetic acid, commonly designated as ATOA, represents a strategically significant pharmaceutical intermediate in the synthesis of third-generation cephalosporin antibiotics. This zwitterionic compound features a precisely configured Z-oxime geometry critical for maintaining stereochemical fidelity during beta-lactam ring formation. As a specialized building block, ATOA enables efficient, scalable production of cefdinir—an essential oral antibiotic used globally to combat respiratory and dermatological infections. Its molecular architecture, incorporating a trityl-protected aminothiazole moiety, provides optimal stability and reactivity for advanced organic synthesis workflows in regulated pharmaceutical environments.

Technical Specifications

Industrial Applications

ATOA serves as an indispensable precursor in cefdinir manufacturing, where its structural precision directly influences the antibiotic's efficacy and safety profile. The compound's trityloxyimino group facilitates controlled deprotection during synthesis, minimizing side reactions and maximizing yield in multi-step API production. Beyond cefdinir, this intermediate demonstrates utility in developing novel antimicrobial agents targeting resistant bacterial strains. Pharmaceutical manufacturers leverage ATOA's consistent reactivity to streamline process validation and reduce production cycle times, particularly in continuous-flow synthesis systems requiring high-purity inputs. Its role extends to analytical reference standards and stability-indicating method development for quality control laboratories.

Quality Assurance Protocols

Our manufacturing process adheres to stringent cGMP standards, ensuring batch-to-batch reproducibility and compliance with ICH guidelines. Key quality attributes include:

• Rigorous HPLC and NMR verification of stereochemical integrity and impurity profiles
• Controlled crystallization techniques yielding optimal particle morphology for downstream processing
• Comprehensive stability testing under ICH climatic zones to validate shelf life
• Trace metal analysis meeting USP <232> and <233> requirements for pharmaceutical intermediates

Each shipment includes a detailed Certificate of Analysis with lot-specific data, spectroscopic validation, and regulatory documentation supporting DMF submissions. Our quality management system is certified to ISO 9001:2015 and undergoes annual third-party audits to maintain the highest industry benchmarks.

Supply Chain Excellence

As a vertically integrated global supplier, we offer scalable production capacity from kilogram to multi-ton quantities with flexible packaging configurations. Standard 25 kg HDPE drums with double-layer polyethylene liners ensure product integrity during international transit, while custom solutions accommodate nitrogen-flushed containers or aseptic filling for specialized applications. Our logistics network provides temperature-monitored shipping with real-time tracking, supported by dedicated technical service teams for synthesis optimization and regulatory guidance. Partner with us for reliable, cost-effective access to premium ATOA intermediates that accelerate your antibiotic development timelines while meeting all pharmacopeial and environmental compliance standards.